Parthenon Capital Invests in RxSense

We served as healthcare regulatory counsel to Parthenon Capital, a growth-oriented private equity firm, in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers. Terms of the transaction were not disclosed.

You Also May Be Interested In:

  • We represented a leading academic medical center in its enterprise software implementation and deployment of Workday, an on‑demand financial management...
    Client Type: Private Company
  • Representation of New Harbor Capital’s portfolio company Psych Associates of Maryland, the largest outpatient mental health group in Maryland, in its acquisition of Comprehensive Behavioral Health, a leading multidisciplinary mental health treatment provider. Terms of the transaction were not disclosed.

    We represented New Harbor Capital's portfolio company Psych Associates of Maryland, the largest outpatient mental health group in Maryland, in...
  • Representation of NVision Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S, in its acquisition of Turner Eye Institute, a LASIK and other eye surgery center. Terms of the transaction were not disclosed.

    We represented NVision Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S, in its...